mezerein and Teratoma

mezerein has been researched along with Teratoma* in 2 studies

Other Studies

2 other study(ies) available for mezerein and Teratoma

ArticleYear
Effect of tumour promoters and non-genotoxic carcinogens on terminal differentiation and proliferation in mouse teratoma XB2 cells cultured in low calcium medium.
    Carcinogenesis, 1990, Volume: 11, Issue:3

    XB2 cells, a teratocarcinoma derived cell line of keratinocyte lineage, have been shown to proliferate and differentiate in low calcium medium (0.03 mM Ca2+) at a density of 500 cells/9.6 cm2 without the need for fibroblast feeder layers or conditioned medium. The degree of differentiation can be assessed by measurements of keratin production and stratification of colonies of cells. Both of these parameters, as well as the proliferative capacity of the cells, can be altered by treatment of the cultures with various promoting agents and non-genotoxic carcinogens. Treatment with teleocidin and 12-O-tetradecanoyl phorbol-13-acetate induced large increases in proliferation, stratification and keratinization; mezerein-treated cells showed increased stratification at higher doses; butylated hydroxyanisole treatment resulted in hyperkeratinization and hyperstratification to lower levels than that seen with the phorbol-ester-like promoters; butylated hydroxytoluene had purely hyperproliferative effects. We suggest that this culture system may provide a useful model for studies of the mechanism of promotion and non-genotoxic carcinogenesis in epithelial tissues.

    Topics: Animals; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Calcium; Carcinogens; Cell Differentiation; Cell Division; Cocarcinogenesis; Diterpenes; Keratins; Lyngbya Toxins; Mice; Teratoma; Terpenes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1990
Characterization of a human teratocarcinoma cell assay for inhibitors of metabolic cooperation.
    Cancer research, 1986, Volume: 46, Issue:3

    Although a Chinese hamster V79 cell-based assay for inhibitors of metabolic cooperation is currently available, the development of a human cell-based assay is desirable in order to avoid inappropriate extrapolation from animal cells to human cells. Cells derived from a human teratocarcinoma cell line (designated PA-1), which has a stable pseudodiploid karyotype and excellent in vitro growth properties, were used in a metabolic cooperation assay. The assay was based on the metabolic isolation of hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-deficient variants in the presence of HGPRT-proficient cells and 6-thioguanine. Chemicals which inhibit the transfer of the lethal metabolite of 6-thioguanine from HGPRT-proficient to HGPRT-deficient cells will allow for recovery of the 6-thioguanine-resistant (HGPRT-deficient) cells. Chemicals tested included 12-O-tetradecanoylphorbol-13-acetate and related analogues phorbol-12,13-didecanoate, mezerein, and 4-phorbol-12,13-didecanoate. Concurring with results previously obtained in V79 cells, 12-O-tetradecanoylphorbol-13-acetate and phorbol-12,13-didecanoate strongly inhibited metabolic cooperation, whereas mezerein was moderately inhibitory and 4 alpha-phorbol-12,13-didecanoate was inactive. These cells thus hold promise as a human cell-based assay for inhibitors of metabolic cooperation.

    Topics: Biological Assay; Cell Communication; Diterpenes; Humans; Hypoxanthine Phosphoribosyltransferase; Intercellular Junctions; Karyotyping; Phorbol Esters; Teratoma; Terpenes; Tetradecanoylphorbol Acetate

1986